Current advances in detecting genetic and epigenetic biomarkers of colorectal cancer

MS Islam, V Gopalan, AKY Lam… - Biosensors and …, 2023 - Elsevier
Colorectal carcinoma (CRC) is the third most common cancer in terms of diagnosis and the
second in terms of mortality. Recent studies have shown that various proteins, such as …

[HTML][HTML] New trends in molecular and cellular biomarker discovery for colorectal cancer

P Aghagolzadeh, R Radpour - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third leading cause of cancer death worldwide, which is
consequence of multistep tumorigenesis of several genetic and epigenetic events. Since …

Current tissue molecular markers in colorectal cancer: a literature review

G Peluso, P Incollingo, A Calogero… - BioMed research …, 2017 - Wiley Online Library
Background. Colorectal cancer (CRC) is one of the most spread neoplasia types all around
the world, especially in western areas. It evolves from precancerous lesions and …

Molecular pathogenesis of colorectal cancer with an emphasis on recent advances in biomarkers, as well as nanotechnology-based diagnostic and therapeutic …

FA Al-Joufi, A Setia, MM Salem-Bekhit, RK Sahu… - Nanomaterials, 2022 - mdpi.com
Colorectal cancer (CRC) is a serious disease that affects millions of people throughout the
world, despite considerable advances in therapy. The formation of colorectal adenomas and …

[HTML][HTML] Diagnostic and therapeutic biomarkers in colorectal cancer: a review

JV de Assis, LA Coutinho, IT Oyeyemi… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is a public health concern and the second most common type of
cancer among men and women causing a significant mortality. Biomarkers closely linked to …

Molecular characterization and biomarker identification in colorectal cancer: Toward realization of the precision medicine dream

G Goel - Cancer management and research, 2018 - Taylor & Francis
Colorectal cancer (CRC) is a major public health problem, both in the USA and globally.
Over the past 20 years, significant advances have been made in the treatment of patients …

[HTML][HTML] Molecular methods for colorectal cancer screening: Progress with next-generation sequencing evolution

S Abbes, S Baldi, H Sellami, A Amedei… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Currently, colorectal cancer (CRC) represents the third most common malignancy and the
second most deadly cancer worldwide, with a higher incidence in developed countries. Like …

Colorectal cancer diagnosis: the obstacles we face in determining a non-invasive test and current advances in biomarker detection

F Kamel, K Eltarhoni, P Nisar, M Soloviev - Cancers, 2022 - mdpi.com
Simple Summary Colorectal cancer (CRC) is one of the most common cancers in the
western world. CRC originates from precursor adenomatous polyps, which may over time …

Biomarkers for colorectal cancer

T Tanaka, M Tanaka, T Tanaka… - International journal of …, 2010 - mdpi.com
Colorectal cancer (CRC) is the third most common epithelial malignancy in the world. Since
CRC develops slowly from removable precancerous lesions, detection of the lesion at an …

Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas

GE Lind, SA Danielsen, T Ahlquist, MA Merok… - Molecular cancer, 2011 - Springer
Background The presence of cancer-specific DNA methylation patterns in epithelial
colorectal cells in human feces provides the prospect of a simple, non-invasive screening …